MORPHEUS-EC: A phase Ib/II open-label, randomized study of first-line tiragolumab (tira) + atezolizumab (atezo) + chemotherapy (CT) in patients (pts) with esophageal cancer (EC) von Sun, Jong-Mu, Chao, Yee, Kim, Sung-Bae, Rha, Sun Young, Evans, T.R. Jeffry, Strickland, Andrew, Wainberg, Zev A., Chau, Ian, Pelles-Avraham, Sharon, Ajani, Jaffer A., Malhotra, Ritu, Liu, Qingyuan, Li, Sijing, Cha, Edward, Rahalkar, Swapna, Allen, Simon, Hsu, Chih-Hung

Volltext